Glycotope
Company Details
Status: Private
Employees: 11-50
Location:
Berlin, Germany
Type:
sample
Technology:
sample
sample
About: Glycotope is a biotechnology company utilizing a proprietary technology platform to develop uniquely tumor-specific monoclonal antibodies. We combine expertise in glycobiology and know-how in antibody development to advance first-in-class antibody-based therapeutics for (immuno)-oncology.
Our antibodies target specific tumor-associated carbohydrate structures or protein/carbohydrate combined glyco-epitopes (GlycoTargets). Based on their superior tumor-specificity, our antibodies are suitable for development in an array of different modes of action including naked antibodies, bispecifics, antibody-drug-conjugates, cellular therapies or fusion-proteins.
Glycotope has to date discovered in excess of 200 GlycoTargets with several antibodies against selected targets under development.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Glycotope | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.